EUROPEAN PARLIAMENT WANTS CONTROL OVER EMA FEES ON PHARMACOS
April 1st, 2016
THE EUROPEAN Parliament has voted for the structure and level of fees charged by the European Medicines Agency (EMA) to be set by MEPs and European Union (EU) ministers, not the European Commission, as at present. The amendment to proposed reforms to EMA’s founding regulation (No 726/2004) has to be accepted by the EU Council of Ministers to go forward. The reform package seeks to clarify how EMA is funded and operates, and MEPs backed amendments that said the agency can draw money from the EU; any non-EU country striking EU agreements over pharma regulation; ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.